Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma

This study has been terminated.
(Study closed following Phase I portion, insufficient activity to continue to Phase II.)
Novartis Pharmaceuticals
Information provided by (Responsible Party):
M.D. Anderson Cancer Center Identifier:
First received: July 18, 2006
Last updated: December 16, 2014
Last verified: December 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2013
  Primary Completion Date: November 2006 (Final data collection date for primary outcome measure)
No publications provided by M.D. Anderson Cancer Center

Publications automatically indexed to this study by Identifier (NCT Number):